메뉴 건너뛰기




Volumn 25, Issue 11, 2008, Pages 1215-1228

Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia

Author keywords

Efficacy; Epoetin zeta; Erythropoietin; Long term safety; Maintenance treatment; Renal anemia

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

EID: 69949150756     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-008-0111-1     Document Type: Article
Times cited : (37)

References (29)
  • 2
    • 0029890251 scopus 로고    scopus 로고
    • Molecular basis of hypoxia-induced erythropoietin expression
    • Wang GL, Semenza GL. Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol. 1996;3:156-162. (Pubitemid 26178055)
    • (1996) Current Opinion in Hematology , vol.3 , Issue.2 , pp. 156-162
    • Wang, G.L.1    Semenza, G.L.2
  • 4
    • 84859432838 scopus 로고    scopus 로고
    • Neuss, Germany: JANSSEN-CILAG GmbH Germany
    • Erypo/Erypo Product information. Neuss, Germany: JANSSEN-CILAG GmbH Germany; 2002.
    • (2002) Erypo/Erypo Product Information
  • 5
    • 0035163281 scopus 로고    scopus 로고
    • Identification of patients and risk factors in chronic kidney disease - Evaluating risk factors and therapeutic strategies
    • Levin A. Identifcation of patients and risk factors in chronic kidney disease-evaluating risk factors and therapeutic strategies. Nephrol Dial Transplant. 2001;16:57-60. (Pubitemid 33062125)
    • (2001) Nephrology Dialysis Transplantation , vol.16 , Issue.SUPPL. 7 , pp. 57-60
    • Levin, A.1
  • 6
    • 84859434984 scopus 로고    scopus 로고
    • Anemia management in patients with chronic renal disease: Current recommendations
    • Tarif N. Anemia management in patients with chronic renal disease: current recommendations. Saudi J Kidney Dis Transpl. 2002;13:331-335.
    • (2002) Saudi J Kidney Dis Transpl , vol.13 , pp. 331-335
    • Tarif, N.1
  • 7
    • 0027010484 scopus 로고
    • Treatment of renal anemia with recombinant human erythropoietin
    • Macdougall IC. Treatment of renal anemia with recombinant human erythropoietin. Curr Opin Nephrol Hypertens. 1992;1:210-219.
    • (1992) Curr Opin Nephrol Hypertens , vol.1 , pp. 210-219
    • MacDougall, I.C.1
  • 8
    • 26944435921 scopus 로고    scopus 로고
    • Quality of life in patients on dialysis: Benefts of maintaining a hemoglobin of 11 to 12 g/dl
    • Gregory N. Quality of life in patients on dialysis: benefts of maintaining a hemoglobin of 11 to 12 g/dL. Nephrol Nurs J. 2005;32:307-310.
    • (2005) Nephrol Nurs J , vol.32 , pp. 307-310
    • Gregory, N.1
  • 9
    • 0030002368 scopus 로고    scopus 로고
    • Long-term impact of recombinant human erythropoietin on transfusion support in patients with chronic renal failure
    • Popovsky MA, Ransil BJ. Long-term impact of recombinant human erythropoietin on transfusion support in patients with chronic renal failure. Immunohematol. 1996;12:1-3. (Pubitemid 26102951)
    • (1996) Immunohematology , vol.12 , Issue.1 , pp. 1-3
    • Popovsky, M.A.1    Ransil, B.J.2
  • 10
    • 0034027195 scopus 로고    scopus 로고
    • Morbidity and mortality reduction associated with the use of erythropoietin
    • Tsakiris D. Morbidity and mortality reduction associated with the use of erythropoietin. Nephron. 2000;85 (suppl. 1):2-8. (Pubitemid 30192921)
    • (2000) Nephron , vol.85 , Issue.SUPPL. 1 , pp. 2-8
    • Tsakiris, D.1
  • 14
    • 41149131276 scopus 로고    scopus 로고
    • Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment
    • DOI 10.1185/030079908X273264
    • Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R. The epoetin zeta study group. Comparison of the therapeutic Effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment. Curr Med Res Opin. 2008;24: 625-637. (Pubitemid 351428973)
    • (2008) Current Medical Research and Opinion , vol.24 , Issue.3 , pp. 625-637
    • Wizemann, V.1    Rutkowski, B.2    Baldamus, C.3    Scigalla, P.4    Koytchev, R.5
  • 15
    • 44349139462 scopus 로고    scopus 로고
    • Comparison of the therapeutic effects of epoetin zeta and epoetin alfa in the correction of renal anaemia
    • DOI 10.1185/030079908X297402
    • Krivoshiev S, Todorov V, Manitius J, Czekalski S, Scigalla P, Koytchev R. Epoetin Zeta Study Group. Comparison of the therapeutic Effects of epoetin zeta and epoetin alfa in the correction of renal anemia. Curr Med Res Opin. 2008;24:1407-1415. (Pubitemid 351741574)
    • (2008) Current Medical Research and Opinion , vol.24 , Issue.5 , pp. 1407-1415
    • Krivoshiev, S.1    Todorov, V.V.2    Manitius, J.3    Czekalski, S.4    Scigalla, P.5    Koytchev, R.6
  • 18
    • 84859426332 scopus 로고    scopus 로고
    • Step 5, Consolidated Guideline from 01.05.1996. Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95). Woden, Australia: TGA Accessed September 2, 2008
    • ICH Topic E 6. Guideline for Good Clinical Practice. Step 5, Consolidated Guideline from 01.05.1996. Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95). Woden, Australia: TGA; 2000. Available at: www.tga.gov.au/docs/pdf/euguide/ich/ich13595.pdf. Accessed September 2, 2008.
    • (2000) ICH Topic e 6. Guideline for Good Clinical Practice
  • 19
    • 4344581912 scopus 로고    scopus 로고
    • Revised european best practice guidelines for the management of anaemia in patients with chronic renal failure
    • Locatelli F, Aljama P, Bárány P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(suppl. 2):1-47.
    • (2004) Nephrol Dial Transplant. , vol.19 , Issue.SUPPL. 2 , pp. 1-47
    • Locatelli, F.1    Aljama, P.2    Bárány, P.3
  • 21
    • 0345059073 scopus 로고    scopus 로고
    • The detection of anti-erythropoietin antibodies in human serum and plasma: Part I. Validation of the protocol for a radioimmunoprecipitation assay
    • DOI 10.1016/j.jim.2003.09.003
    • Tacey R, Greyway A, Smiell J, et al. The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. J Immunol Meth. 2003;283:317-329. (Pubitemid 37501079)
    • (2003) Journal of Immunological Methods , vol.283 , Issue.1-2 , pp. 317-329
    • Tacey, R.1    Greway, A.2    Smiell, J.3    Power, D.4    Kromminga, A.5    Daha, M.6    Casadevall, N.7    Kelley, M.8
  • 22
    • 4043133064 scopus 로고    scopus 로고
    • Epoetin-induced autoimmune pure red cell aplasia
    • Casadevall N. Epoetin-induced autoimmune pure red cell aplasia. Hematol J. 2004;5(suppl. 3):104-109.
    • (2004) Hematol J. , vol.5 , Issue.SUPPL. 3 , pp. 104-109
    • Casadevall, N.1
  • 24
    • 0032572915 scopus 로고    scopus 로고
    • Erythropoietin for end-stage renal disease
    • DOI 10.1056/NEJM199808273390910
    • Adamson JW, Eschbach JW. Erythropoietin for end-stage renal disease. N Engl J Med. 1998;339;625-627. (Pubitemid 28385662)
    • (1998) New England Journal of Medicine , vol.339 , Issue.9 , pp. 625-627
    • Adamson, J.W.1    Eschbach, J.W.2
  • 25
    • 84859423269 scopus 로고    scopus 로고
    • Toronto, ON: Janssen-Ortho CA Inc.
    • Eprex Product information. Toronto, ON: Janssen-Ortho CA Inc.; 2006.
    • (2006) Eprex Product Information
  • 26
    • 84859422377 scopus 로고    scopus 로고
    • NeoRecormon Product information
    • Hertfordshire: Roche Registration Ltd.
    • NeoRecormon Product information. Welwyn Garden City, Hertfordshire: Roche Registration Ltd.; 2002.
    • (2002) Welwyn Garden City


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.